Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pulmonary Embolism × isoquercitrin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Classical hematology 1

Conditions

Venous Thrombosis 1 Venous Thromboembolism 1 Thromboembolism 1 Pulmonary Embolism 1 Pancreatic Neoplasms 1

Interventions

Dalteparin 5 apixaban 4 abelacimab 2 MAA868 2 isoquercitrin 1 edoxaban 1 bemiparin 1 Tinzaparin 1 Heparin, Low-Molecular-Weight 1 Dabigatran 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06861088 2026-02-02

CATIQ P3

Quercis Pharma AG

Phase 3 Recruiting

Classical hematologyGastrointestinal

Pancreatic Neoplasms, Pulmonary Embolism, Thromboembolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡